Mycobacterium tuberculosis induces CCL18 expression in human macrophages

Scandinavian Journal of Immunology

Volumn 68, Issue 6, 2008, Pages 668-674

  Ferrara, G ^a,b,c   Bleck, B ^b   Richeldi, L ^c   Reibman, J ^b   Fabbri, L M ^c   Rom, W N ^b   Condos, R ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CHEMOKINE; CHEMOKINE CCL18; COLONY STIMULATING FACTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR ALPHA; LIPOPOLYSACCHARIDE; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LUNG ALVEOLUS MACROPHAGE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

CELLS, CULTURED; CHEMOKINES, CC; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; RNA, MESSENGER; TUBERCULOSIS, PULMONARY;

EID: 55349085131     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02182.x     Document Type: Article

References (29)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999 282 : 677 86.
2. Espinal MA, Laszlo A, Simonsen L et al. Global trends in resistance to antituberculosis drugs. World Health Organization - International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 2001 344 : 1294 303.
3. Ainslie GM, Solomon JA, Bateman ED. Lymphocyte and lymphocyte subset numbers in blood and in bronchoalveolar lavage and pleural fluid in various forms of human pulmonary tuberculosis at presentation and during recovery. Thorax 1992 47 : 513 8.
4. Hoheisel GB, Tabak L, Teschler H, Erkan F, Kroegel C, Costabel U. Bronchoalveolar lavage cytology and immunocytology in pulmonary tuberculosis. Am J Respir Crit Care Med 1994 149 : 460 3.
5. Law KF, Jagirdar J, Weiden MD, Bodkin M, Rom WN. Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. Am J Respir Crit Care Med 1996 153 : 1377 84.
6. Yu CT, Wang CH, Huang TJ, Lin HC, Kuo HP. Relation of bronchoalveolar lavage T lymphocyte subpopulations to rate of regression of active pulmonary tuberculosis. Thorax 1995 50 : 869 74.
7. Ancochea J, Gonzalez A, Sanchez MJ, Aspa J, Lopez-Botet M. Expression of lymphocyte activation surface antigens in bronchoalveolar lavage and peripheral blood cells from young healthy subjects. Chest 1993 104 : 32 7.
8. Gett AV, Sallusto F, Lanzavecchia A, Geginat J. T cell fitness determined by signal strength. Nat Immunol 2003 4 : 355 60.
9. Raju B, Tung CF, Cheng D et al. In situ activation of helper T cells in the lung. Infect Immunol 2001 69 : 4790 8.
10. Adema GJ, Hartgers F, Verstraten R et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 1997 387 : 713 7.
11. Lindhout E, Vissers JL, Hartgers FC et al. The dendritic cell-specific CC-chemokine DC-CK1 is expressed by germinal center dendritic cells and attracts CD38-negative mantle zone B lymphocytes. J Immunol 2001 166 : 3284 9.
12. Schraufstatter I, Takamori H, Sikora L, Sriramarao P, DiScipio RG. Eosinophils and monocytes produce pulmonary and activation-regulated chemokine (PARC/CCL18), which activates cultured monocytes/macrophages. Am J Physiol Lung Cell Mol Physiol 2004 286 : L494 501.
13. Kodelja V, Muller C, Politz O, Hakij N, Orfanos CE, Goerdt S. Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. J Immunol 1998 160 : 1411 8.
14. Giacomini E, Iona E, Ferroni L et al. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol 2001 166 : 7033 41.
15. Jamieson SE, Miller EN, Black GF et al. Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians. Genes Immunol 2004 5 : 46 57.
16. Porcheray F, Viaud S, Rimaniol AC et al. Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol 2005 142 : 481 9.
17. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003 3 : 23 35.
18. Sordet O, Rébé C, Plenchette S et al. Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood 2002 100 : 4446 53.
19. Vulcano M, Struyf S, Scapini P et al. Unique regulation of CCL18 production by maturing dendritic cells. J Immunol 2003 170 : 3843 9.
20. + peripheral blood monocytes. J Immunol 1996 157 : 3850 9.
21. Schutyser E, Struyf S, Wuyts A et al. Selective induction of CCL18/PARC by staphylococcal enterotoxins in mononuclear cells and enhanced levels in septic and rheumatoid arthritis. Eur J Immunol 2001 31 : 3755 62.
22. Tobian AA, Potter NS, Ramachandra L et al. Alternate class I MHC antigen processing is inhibited by toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide. J Immunol 2003 171 : 1413 22.
23. Pai RK, Pennini ME, Tobian AA, Canaday DH, Boom WH, Harding CV. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kDa lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages. Infect Immunol 2004 72 : 6603 14.
24. Ozinsky A, Underhill DM, Fontenot JD et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 2000 97 : 13766 71.
25. Boot RG, Verhoek M, de Fost M et al. Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention. Blood 2004 103 : 33 9.
26. Honda Y, Rogers L, Nakata K et al. Type I interferon induces inhibitory 16-kDa CCAAT/enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J Exp Med 1998 188 : 1255 65.
27. Van den Heuvel MM, Tensen CP, van As JH et al. Regulation of CD163 on human macrophages: cross-linking of CD163 induces signaling and activation. J Leukoc Biol 1999 66 : 858 66.
28. Schutyser E, Struyf S, Proost P et al. Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma. J Biol Chem 2002 277 : 24584 93.
29. Beverley PC. Functional analysis of human T cell subsets defined by CD45 isoform expression. Semin Immunol 1992 4 : 35 41.